SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

08 Aug 2022 Evaluate
The total revenue hovered 804.35% to Rs. 2.08 millions for the June 2022 quarter as against Rs. 0.23 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 124.14% to Rs. 1.95  millions  from Rs. 0.87 millions in previous same quarter.Operating Profit saw a handsome growth to 2.88 millions from 1.01 millions in the quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2.08 0.23 804.35 2.08 0.23 804.35 3.65 69.91 -94.78
Other Income 4.41 3.78 16.67 4.41 3.78 16.67 19.19 14.66 30.90
PBIDT 2.88 1.01 185.15 2.88 1.01 185.15 10.25 23.12 -55.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.88 1.01 185.15 2.88 1.01 185.15 10.25 23.12 -55.67
Depreciation 0.23 0.14 64.29 0.23 0.14 64.29 0.92 0.58 58.62
PBT 2.65 0.87 204.60 2.65 0.87 204.60 9.33 22.54 -58.61
TAX 0.70 0.00 0.00 0.70 0.00 0.00 4.57 8.05 -43.23
Deferred Tax 0.70 0.00 0.00 0.70 0.00 0.00 0.22 4.48 -95.09
PAT 1.95 0.87 124.14 1.95 0.87 124.14 4.76 14.49 -67.15
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 138.46 439.13 -68.47 138.46 439.13 -68.47 280.82 33.07 749.15

Emmessar Biotech&Nut Share Price

26.29 -0.70 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×